COFERON
Coferon is a biotechnology company that employs bioorthogonal linker chemistry to deliver therapeutic molecules in component parts that self assembles inside target cells. The Company is based at the Long Island High Tech Incubator on the campus of Stony Brook University in Stony Brook, New York.
COFERON
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2009-01-01
Address:
Stony Brook, New York, United States
Country:
United States
Website Url:
http://www.coferon.com
Total Employee:
11+
Status:
Active
Contact:
8009838097
Email Addresses:
[email protected]
Total Funding:
28.33 M USD
Technology used in webpage:
Black Lotus Hover Webair
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Current Advisors List
Current Employees Featured
Founder
Investors List
MedImmune Ventures
MedImmune Ventures investment in Series B - Coferon
Ascent Biomedical Ventures
Ascent Biomedical Ventures investment in Series B - Coferon
Hatteras Venture Partners
Hatteras Venture Partners investment in Series B - Coferon
Official Site Inspections
http://www.coferon.com
- Host name: earthflax.hostry.com
- IP address: 185.186.245.220
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "Coferon"
Coferon - Crunchbase Company Profile & Funding
Coferon is a biotechnology company that employs bioorthogonal linker chemistry to deliver therapeutic molecules in component parts that self assembles inside target cells. The …See details»
Coferon - Funding, Financials, Valuation & Investors - Crunchbase
Coferon is funded by 3 investors. MedImmune Ventures and Ascent Biomedical Ventures are the most recent investors. Coferon has a post-money valuation in the range of $50M to $100M as …See details»
Coferon Inc - Company Profile and News - Bloomberg Markets
Company profile page for Coferon Inc including stock price, company news, executives, board members, and contact informationSee details»
Coferon - VentureRadar
The Coferon approach utilizes proprietary bioorthogonal linker chemistry to deliver small molecules in component parts that are designed to self assemble on the target inside the cell - …See details»
Coferon - The Org
Coferon employs bioorthogonal linker chemistry to deliver therapeutic molecules in component parts that self assembles inside target cells. Industries Biotechnology , Pharmaceutical + 1See details»
Coferon
Jan 20, 2025 Tercatat dalam beberapa tahun terakhir, terjadi perkembangan yang sangat pesat untuk teknologi digital dalam penyimpanan video yang terbaru. Antusias masyarakat masa kini …See details»
Don Bergstrom Ph.D Profile: Contact Information & Network
Dr. Don Bergstrom co-founded BlinkBio. One of three academic co-founders of Coferon in 2009, he has collaborated with Coferon since, making important contributions to the early proof-of …See details»
AZ fund and others back Coferon's $12m round for 'IKEA' drug …
Three new investors led a $12 million Series B financing round to fund further preclinical development and therapeutic candidate selection for Coferon, a New York-based virtual …See details»
COFERON, INC. - Indiana Company
COFERON, INC. COFERON, INC. (Business ID: 2010032500557) was incorporated on 03/25/2010 in Indiana. Their business is recorded as Foreign For-Profit Corporation. The …See details»
Coferon-动脉网 - vbdata.cn
Jan 1, 2009 Coferon采用生物正交接头化学技术，在靶组织内部自组装的组成部分中提供治疗性分子。该公司目前正在进行表观遗传调控领域的研究和开发项目（最初的重点是BRD家族）和 …See details»
Combinatorial Ubiquitination REal-time PROteolysis (CURE-PROs): …
Apr 11, 2024 Although numerous PROTACs have entered clinical trials, their development remains challenging, and their large size can produce poor drug-like properties. To overcome …See details»
美国化学文摘社宣布收录第一亿个化合物 - 科学网
Jul 7, 2015 全球化学信息权威机构美国化学文摘社（cas）近期在cas 物质数据库(cas registrysm)中收录了第1亿个化学物质。同时今年也是cas 物质数据库作为全球最大 ...See details»
COPERION- WHO WE ARE
We are 5,000 employees worldwide, combining engineering expertise, quality and reliabilitySee details»
Pearl Organisation | Digital Transformation and IT Services
Pearl Organisation is a global leader in developing the technologies at the heart of our connected world. Powered by the research and innovation of Pearl Organisation Technology Services, …See details»
Coffecorn forte, drażetki, 12 szt. - DOZ.pl
Coffecorn forte, drażetki, 12 szt. w portalu DOZ.pl. Zobacz opis i cenę produktu. Zamów on-line.See details»
Alferon
Welcome to Alferon, Nithia’s dedicated organization for providing strategic excellence across sectors with bespoke services focusing on strategic advisory, technical assistance, financial …See details»
Cofmin LS Syrup: View Uses, Side Effects, Price and Substitutes - 1mg
Feb 9, 2025 Cofmin LS Syrup is used in the treatment of Cough with mucus. View Cofmin LS Syrup (bottle of 100.0 ml Syrup) uses, composition, side-effects, price, substitutes, drug …See details»
Home - Xpandium Coberon Ltd
Our use of cookies. We use essential cookies to make this website work. We would also like to set additional cookies to enhance your user experience, help us understand how you use …See details»
Coffecorn forte, drażetki, 1 mg + 100 mg - Leki.pl
Coffecorn forte może powodować różne działania niepożądane. W czasie leczenia ergotaminą mogą wystąpić zaburzenia ze strony ośrodkowego układu nerwowego takie jak parestezje …See details»
10 Organizational Issues (With Causes and Solutions)
Sep 9, 2024 To promote innovation and creativity in the organization, you can encourage employees to think differently, discuss new ideas, implement fresh strategies, and experiment. …See details»